Esperion Therapeutics | ESPR - Capital Social Ordinario





Capital Social Ordinario Cambio Fecha
AbbVie USD 1.77B 1.75B 2025-06
Alnylam Pharmaceuticals USD 133.44M 1.07M 2026-03
Alterity Therapeutics Limited AUD 10.88B 10.66B 2025-12
Amarin USD 20.81M 13K 2025-12
Amgen USD 540M 1000K 2026-03
Biogen USD 146.7M 200K 2025-09
BioMarin Pharmaceutical USD 193.27M 969K 2026-03
Cipla INR 807.78M 17K 2026-03
CSL USD 482.13M 93.87M 2025-12
Cytokinetics USD 124.43M 2.17M 2026-03
Daiichi Sankyo JPY 1.85B 9K 2025-12
Eli Lilly USD 943.5M 3.33M 2026-03
Esperion Therapeutics USD 245.22M 39.79M 2025-12
Geron USD 640.9M 2.54M 2026-03
Grifols EUR 680.58M 846.11K 2025-12
Halozyme Therapeutics USD 118.52M 741K 2026-03
Heron Therapeutics USD 188.31M 4.99M 2025-12
Ionis Pharmaceuticals USD 165.9M 3.93M 2026-03
Merck USD 2.47B 12.72M 2025-12
Minerva Neurosciences USD 1000 0 2024-09
Moderna USD 391M 2M 2025-09
Nektar Therapeutics USD 20.38M 20.36M 2025-12
Pfizer USD 5.7B 13M 2026-03
PTC Therapeutics USD 81.47M 1.54M 2025-12
Puma Biotechnology USD 5K 0 2024-06
Regeneron Pharmaceuticals USD 105M 300K 2026-03
Sanofi EUR 1.21B 8.25M 2026-03
Sarepta Therapeutics USD 105.57M 607K 2026-03
United Therapeutics USD 42.16M 1.49M 2026-03
Vanda Pharmaceuticals USD 58K 0 2024-12